NCT05206500View on ClinicalTrials.gov

NextGen - Clinical Implication of Next Generation Sequencing

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 17, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Urinary Tract Infections
Interventions
DRUG

Antibiotic

FDA approved and marketed antibiotic treatment for the patients with UTI symptoms and CC \>0 and \<10,000

DEVICE

Next Gen

Next Generation Sequencing (NGS) is available to detect bacteria in urine based on bacterial genomes.

Trial Locations (1)

27157

RECRUITING

Wake Forest Health Sciences, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER